Martin Bopst

747 total citations
14 papers, 599 citations indexed

About

Martin Bopst is a scholar working on Molecular Biology, Immunology and Small Animals. According to data from OpenAlex, Martin Bopst has authored 14 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Small Animals. Recurrent topics in Martin Bopst's work include Peroxisome Proliferator-Activated Receptors (4 papers), Immune Response and Inflammation (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Martin Bopst is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (4 papers), Immune Response and Inflammation (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Martin Bopst collaborates with scholars based in Switzerland, United States and China. Martin Bopst's co-authors include Hans‐Pietro Eugster, Matthew B. Wright, Michele Bortolini, Karl Frei, Moh Tadayyon, Cris S. Constantinescu, A. Fontana, Ehud Lavi, Bogdana Balas and Steven D. Cohen and has published in prestigious journals such as The Journal of Experimental Medicine, Hepatology and European Journal of Immunology.

In The Last Decade

Martin Bopst

14 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Bopst Switzerland	9	207	201	99	98	88	14	599
Hitoshi Teraoka Japan	9	141 0.7×	129 0.6×	61 0.6×	125 1.3×	71 0.8×	40	518
H Senoh Japan	6	142 0.7×	350 1.7×	153 1.5×	124 1.3×	114 1.3×	14	771
Dorothy B. Colagiovanni United States	11	248 1.2×	143 0.7×	119 1.2×	63 0.6×	88 1.0×	24	634
Dominique Fokan Belgium	10	228 1.1×	144 0.7×	68 0.7×	93 0.9×	55 0.6×	11	502
Frédérique Bulle France	14	389 1.9×	63 0.3×	123 1.2×	107 1.1×	45 0.5×	26	723
Hongdi Ma China	10	226 1.1×	231 1.1×	51 0.5×	83 0.8×	39 0.4×	13	560
Maha E. Houssen Egypt	13	130 0.6×	102 0.5×	64 0.6×	53 0.5×	31 0.4×	27	455
Yuhong Shen United States	11	386 1.9×	351 1.7×	72 0.7×	452 4.6×	45 0.5×	13	956
Yin‐Hu Wang United States	17	192 0.9×	353 1.8×	142 1.4×	99 1.0×	20 0.2×	34	755

Countries citing papers authored by Martin Bopst

Since Specialization

Citations

This map shows the geographic impact of Martin Bopst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Bopst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Bopst more than expected).

Fields of papers citing papers by Martin Bopst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Bopst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Bopst. The network helps show where Martin Bopst may publish in the future.

Co-authorship network of co-authors of Martin Bopst

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Bopst. A scholar is included among the top collaborators of Martin Bopst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Bopst. Martin Bopst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Bopst, Martin, et al.. (2023). Unexpected neurotoxicity in chronic toxicity studies with a HBV viral expression inhibitor. Regulatory Toxicology and Pharmacology. 141. 105407–105407. 9 indexed citations

2.

Funk, Juergen, Martin Bopst, Giorgio Ottaviani, et al.. (2018). An innovative investigative approach to characterize the effects observed in a combined fertility study in male and female rats. Regulatory Toxicology and Pharmacology. 95. 339–347. 3 indexed citations

3.

Bopst, Martin, et al.. (2017). Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite. Regulatory Toxicology and Pharmacology. 86. 107–116. 3 indexed citations

4.

Schütte, Katrin, Marlies Halder, Klaus Cußler, et al.. (2017). Modern science for better quality control of medicinal products “Towards global harmonization of 3Rs in biologicals”: The report of an EPAA workshop. Biologicals. 48. 55–65. 21 indexed citations

5.

Ottaviani, Giorgio, et al.. (2015). Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias. Regulatory Toxicology and Pharmacology. 73(2). 509–514. 5 indexed citations

6.

Garbe, Joerg H.O., et al.. (2014). Historical Data Analyses and Scientific Knowledge Suggest Complete Removal of the Abnormal Toxicity Test as a Quality Control Test. Journal of Pharmaceutical Sciences. 103(11). 3349–3355. 17 indexed citations

7.

Wright, Matthew B., Michele Bortolini, Moh Tadayyon, & Martin Bopst. (2014). Minireview: Challenges and Opportunities in Development of PPAR Agonists. Molecular Endocrinology. 28(11). 1756–1768. 131 indexed citations

8.

Bortolini, Michele, Matthew B. Wright, Martin Bopst, & Bogdana Balas. (2012). Examining the safety of PPAR agonists – current trends and future prospects. Expert Opinion on Drug Safety. 12(1). 65–79. 62 indexed citations

9.

Bopst, Martin, Irène Garcia, Reto Guler, et al.. (2001). Differential effects of TNF and LTα in the host defense againstM. bovis BCG. European Journal of Immunology. 31(6). 1935–1943. 50 indexed citations

10.

Bopst, Martin, Cordula Haas, Bruce D. Car, & Hans‐Pietro Eugster. (1998). The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin. European Journal of Immunology. 28(12). 4130–4137. 42 indexed citations

11.

Boess, Franziska, et al.. (1998). Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-α gene knockout mice. Hepatology. 27(4). 1021–1029. 81 indexed citations

12.

Boess, Franziska, et al.. (1998). Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-α gene knockout in mice. European Journal of Gastroenterology & Hepatology. 10(7). 626–626. 1 indexed citations

13.

Bopst, Martin, Cordula Haas, Bruce D. Car, & Hans‐Pietro Eugster. (1998). The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin. European Journal of Immunology. 28(12). 4130–4137. 2 indexed citations

14.

Frei, Karl, Hans‐Pietro Eugster, Martin Bopst, et al.. (1997). Tumor Necrosis Factor α and Lymphotoxin α Are Not Required for Induction of Acute Experimental Autoimmune Encephalomyelitis. The Journal of Experimental Medicine. 185(12). 2177–2182. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact